Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 360.565 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-25-000004 · wk-form4_1760044108.xml · derivative · entry 7 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,418.1787 Underlying: Common Shares · 360.565 shares Expires 2026-02-22 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 43.4925 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-25-000004 · wk-form4_1760044108.xml · derivative · entry 6 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,875.3743 Underlying: Common Shares · 43.4925 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 21.9547 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-25-000004 · wk-form4_1760044108.xml · derivative · entry 5 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461.05 Underlying: Common Shares · 21.9547 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 304.075 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000278 · wk-form4_1752181336.xml · derivative · entry 12 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,585.5731 Underlying: Common Shares · 304.075 shares Expires 2028-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 67.1768 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000278 · wk-form4_1752181336.xml · derivative · entry 11 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,419.7843 Underlying: Common Shares · 67.1768 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 252.7679 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000278 · wk-form4_1752181336.xml · derivative · entry 10 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,918.6248 Underlying: Common Shares · 252.7679 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 70.985 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000278 · wk-form4_1752181336.xml · derivative · entry 9 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,840.4068 Underlying: Common Shares · 70.985 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 217.6027 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000278 · wk-form4_1752181336.xml · derivative · entry 8 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,034.5682 Underlying: Common Shares · 217.6027 shares Expires 2026-02-22 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 45.8892 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000278 · wk-form4_1752181336.xml · derivative · entry 7 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,068.5365 Underlying: Common Shares · 45.8892 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 30.2977 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000278 · wk-form4_1752181336.xml · derivative · entry 6 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,346.4297 Underlying: Common Shares · 30.2977 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 17:02 UTC |
KLEIN JEFFREY WPresident, Popeyes-US & Canada
|
GrantPerformance Share Units · Derivative | 318.2184 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000280 · wk-form4_1752181362.xml · derivative · entry 7 KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,147.7401 Underlying: Common Shares · 318.2184 shares Expires 2028-03-15 F9 · derivative.exercise_price: The shares reported represent an award of performance base share units (the "2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning on February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 17:02 UTC |
KLEIN JEFFREY WPresident, Popeyes-US & Canada
|
GrantRestricted Share Units · Derivative | 64.3463 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000280 · wk-form4_1752181362.xml · derivative · entry 6 KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,107.1472 Underlying: Common Shares · 64.3463 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F8 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 17:02 UTC |
KLEIN JEFFREY WPresident, Popeyes-US & Canada
|
GrantPerformance Share Units · Derivative | 210.9353 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000280 · wk-form4_1752181362.xml · derivative · entry 5 KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,298.1408 Underlying: Common Shares · 210.9353 shares Expires 2027-03-15 F7 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance period. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 17:02 UTC |
KLEIN JEFFREY WPresident, Popeyes-US & Canada
|
GrantPerformance Share Units · Derivative | 94.2945 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000280 · wk-form4_1752181362.xml · derivative · entry 4 KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,414.9796 Underlying: Common Shares · 94.2945 shares Expires 2026-02-22 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 17:02 UTC |
KLEIN JEFFREY WPresident, Popeyes-US & Canada
|
GrantRestricted Share Units · Derivative | 34.5446 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000280 · wk-form4_1752181362.xml · derivative · entry 3 KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,815.5033 Underlying: Common Shares · 34.5446 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 17:02 UTC |
KLEIN JEFFREY WPresident, Popeyes-US & Canada
|
GrantRestricted Share Units · Derivative | 14.841 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000280 · wk-form4_1752181362.xml · derivative · entry 2 KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,639.214 Underlying: Common Shares · 14.841 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F3 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
SANTELMO THIAGO TPresident, International
|
GrantPerformance Share Units · Derivative | 367.7205 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000279 · wk-form4_1752181350.xml · derivative · entry 13 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,615.3248 Underlying: Common Shares · 367.7205 shares Expires 2028-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning on February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
SANTELMO THIAGO TPresident, International
|
GrantRestricted Share Units · Derivative | 65.7753 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000279 · wk-form4_1752181350.xml · derivative · entry 12 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,264.9933 Underlying: Common Shares · 65.7753 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 2027 and December 2028. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 2027 and December 2028. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
SANTELMO THIAGO TPresident, International
|
GrantPerformance Share Units · Derivative | 272.2314 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000279 · wk-form4_1752181350.xml · derivative · entry 11 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,068.3968 Underlying: Common Shares · 272.2314 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance period. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
SANTELMO THIAGO TPresident, International
|
GrantPerformance Share Units · Derivative | 174.0822 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000279 · wk-form4_1752181350.xml · derivative · entry 10 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,227.6546 Underlying: Common Shares · 174.0822 shares Expires 2026-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
SANTELMO THIAGO TPresident, International
|
GrantRestricted Share Units · Derivative | 40.4131 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000279 · wk-form4_1752181350.xml · derivative · entry 9 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,463.6969 Underlying: Common Shares · 40.4131 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F7 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
SANTELMO THIAGO TPresident, International
|
GrantRestricted Share Units · Derivative | 38.8717 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000279 · wk-form4_1752181350.xml · derivative · entry 8 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,293.438 Underlying: Common Shares · 38.8717 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
SANTELMO THIAGO TPresident, International
|
GrantRestricted Share Units · Derivative | 16.6949 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000279 · wk-form4_1752181350.xml · derivative · entry 7 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,843.9741 Underlying: Common Shares · 16.6949 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 565.7288 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000274 · wk-form4_1752181286.xml · derivative · entry 8 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,485.6634 Underlying: Common Shares · 565.7288 shares Expires 2028-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 86.5203 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000274 · wk-form4_1752181286.xml · derivative · entry 7 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,556.3074 Underlying: Common Shares · 86.5203 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 568.7278 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000274 · wk-form4_1752181286.xml · derivative · entry 6 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,816.9057 Underlying: Common Shares · 568.7278 shares Expires 2027-03-15 F8 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 103.7671 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000274 · wk-form4_1752181286.xml · derivative · entry 5 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,461.2416 Underlying: Common Shares · 103.7671 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F7 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 435.2054 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000274 · wk-form4_1752181286.xml · derivative · entry 4 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,069.1364 Underlying: Common Shares · 435.2054 shares Expires 2026-02-22 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 44.6508 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000274 · wk-form4_1752181286.xml · derivative · entry 3 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,931.7544 Underlying: Common Shares · 44.6508 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 23.3279 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000274 · wk-form4_1752181286.xml · derivative · entry 2 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,576.6044 Underlying: Common Shares · 23.3279 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F3 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:03 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantPerformance Share Units · Derivative | 7,433.0786 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000282 · wk-form4_1752181386.xml · derivative · entry 5 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 820,995.5236 Underlying: Common Shares · 7,433.0786 shares Expires not disclosed F5 · derivative.exercise_price: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F5 · derivative.expiration_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:03 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantRestricted Share Units · Derivative | 2,973.2315 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000282 · wk-form4_1752181386.xml · derivative · entry 4 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,398.2094 Underlying: Common Shares · 2,973.2315 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in five equal annual installments. The remaining vestings will occur on November 21, 2025, November 21, 2026 and November 21, 2027. F4 · derivative.expiration_date: These restricted share units vest in five equal annual installments. The remaining vestings will occur on November 21, 2025, November 21, 2026 and November 21, 2027. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 155.5687 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000277 · wk-form4_1752181324.xml · derivative · entry 9 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,182.8191 Underlying: Common Shares · 155.5687 shares Expires 2028-03-15 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning on February 28, 2025 and ending on February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 40.6878 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000277 · wk-form4_1752181324.xml · derivative · entry 8 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,494.0307 Underlying: Common Shares · 40.6878 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F10 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 155.9364 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000277 · wk-form4_1752181324.xml · derivative · entry 7 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,223.4302 Underlying: Common Shares · 155.9364 shares Expires 2027-03-15 F9 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 47.1868 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000277 · wk-form4_1752181324.xml · derivative · entry 6 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,211.8554 Underlying: Common Shares · 47.1868 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F8 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 130.5616 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000277 · wk-form4_1752181324.xml · derivative · entry 5 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,420.7409 Underlying: Common Shares · 130.5616 shares Expires 2026-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 34.2818 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000277 · wk-form4_1752181324.xml · derivative · entry 4 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,786.4758 Underlying: Common Shares · 34.2818 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:02 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 18.4603 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000277 · wk-form4_1752181324.xml · derivative · entry 3 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,038.9665 Underlying: Common Shares · 18.4603 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 388.9357 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000275 · wk-form4_1752181298.xml · derivative · entry 11 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,958.5753 Underlying: Common Shares · 388.9357 shares Expires 2028-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 90.3189 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000275 · wk-form4_1752181298.xml · derivative · entry 10 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,975.8725 Underlying: Common Shares · 90.3189 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 315.9599 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000275 · wk-form4_1752181298.xml · derivative · entry 9 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,898.281 Underlying: Common Shares · 315.9599 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 104.4721 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000275 · wk-form4_1752181298.xml · derivative · entry 8 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,539.109 Underlying: Common Shares · 104.4721 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 326.404 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000275 · wk-form4_1752181298.xml · derivative · entry 7 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,051.8523 Underlying: Common Shares · 326.404 shares Expires 2026-02-22 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 70.5194 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000275 · wk-form4_1752181298.xml · derivative · entry 6 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,788.9804 Underlying: Common Shares · 70.5194 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:01 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 43.6046 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000275 · wk-form4_1752181298.xml · derivative · entry 5 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,816.1988 Underlying: Common Shares · 43.6046 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:03 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,414.3175 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000283 · wk-form4_1752181398.xml · derivative · entry 10 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,213.6493 Underlying: Common Shares · 1,414.3175 shares Expires 2028-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning on February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:03 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 180.0386 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000283 · wk-form4_1752181398.xml · derivative · entry 9 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,885.5514 Underlying: Common Shares · 180.0386 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:03 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,137.4652 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000283 · wk-form4_1752181398.xml · derivative · entry 8 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,634.8638 Underlying: Common Shares · 1,137.4652 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:03 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 219.0808 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000283 · wk-form4_1752181398.xml · derivative · entry 7 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,197.8251 Underlying: Common Shares · 219.0808 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.